Global Adalimumab Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

  • ID:PD039205
  • May 2020
  • GIR (Global Info Research)
                          

The Global Adalimumab Market Report is equipped with market data from 2015 to 2025. The report gives a market overview covering key drivers and risks factors. The report is bifurcated by top global manufactures mentioning sales, revenue and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2020 to 2025. The detailed sales channel is also covered in the study.

The global Adalimumab market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 0.2% in the forecast period of 2020 to 2025 and will expected to reach USD 882.4 million by 2025, from USD 874.8 million in 2019.

The Adalimumab market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market Segmentation
Adalimumab market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Adalimumab market has been segmented into

  • Oral Type
  • Injection Type

By Application, Adalimumab has been segmented into:
  • Rheumatoid Arthritis
  • Psoriasis
  • Crohn’s Disease
  • Ulcerative Colitis
  • Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Adalimumab market presented in the report. This section sheds light on the sales growth of different regional and country-level Adalimumab markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Adalimumab market.

The report offers in-depth assessment of the growth and other aspects of the Adalimumab market in important countries (regions), including:
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, UK, Russia and Italy)
  • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • South America (Brazil, Argentina, etc.)
  • Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Adalimumab Market Share Analysis
Adalimumab competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Adalimumab sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Adalimumab sales, revenue and market share for each player covered in this report.

The major players covered in Adalimumab are:
  • AbbVie, Inc.
  • Eisai Co., Ltd.
  • Amgen, Inc.
  • Pfizer, Inc.
  • Boehringer Ingelheim GmbH
  • Novartis AG
  • Mylan N.V.

Among other players domestic and global, Adalimumab market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. 

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Adalimumab product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Adalimumab, with price, sales, revenue and global market share of Adalimumab in 2018 and 2019.
Chapter 3, the Adalimumab competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Adalimumab breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Adalimumab market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Adalimumab sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
1.1 Adalimumab Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Adalimumab Revenue by Type
1.2.2 Oral Type
1.2.3 Injection Type
1.3 Market Analysis by Application
1.3.1 Overview: Global Adalimumab Revenue by Application
1.3.2 Rheumatoid Arthritis
1.3.3 Psoriasis
1.3.4 Crohn’s Disease
1.3.5 Ulcerative Colitis
1.3.6 Others
1.4 Overview of Global Adalimumab Market
1.4.1 Global Adalimumab Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AbbVie, Inc.
2.1.1 AbbVie, Inc. Details
2.1.2 AbbVie, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AbbVie, Inc. SWOT Analysis
2.1.4 AbbVie, Inc. Product and Services
2.1.5 AbbVie, Inc. Adalimumab Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Eisai Co., Ltd.
2.2.1 Eisai Co., Ltd. Details
2.2.2 Eisai Co., Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Eisai Co., Ltd. SWOT Analysis
2.2.4 Eisai Co., Ltd. Product and Services
2.2.5 Eisai Co., Ltd. Adalimumab Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Amgen, Inc.
2.3.1 Amgen, Inc. Details
2.3.2 Amgen, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Amgen, Inc. SWOT Analysis
2.3.4 Amgen, Inc. Product and Services
2.3.5 Amgen, Inc. Adalimumab Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer, Inc.
2.4.1 Pfizer, Inc. Details
2.4.2 Pfizer, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer, Inc. SWOT Analysis
2.4.4 Pfizer, Inc. Product and Services
2.4.5 Pfizer, Inc. Adalimumab Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Boehringer Ingelheim GmbH
2.5.1 Boehringer Ingelheim GmbH Details
2.5.2 Boehringer Ingelheim GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Boehringer Ingelheim GmbH SWOT Analysis
2.5.4 Boehringer Ingelheim GmbH Product and Services
2.5.5 Boehringer Ingelheim GmbH Adalimumab Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis AG
2.6.1 Novartis AG Details
2.6.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis AG SWOT Analysis
2.6.4 Novartis AG Product and Services
2.6.5 Novartis AG Adalimumab Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Mylan N.V.
2.7.1 Mylan N.V. Details
2.7.2 Mylan N.V. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Mylan N.V. SWOT Analysis
2.7.4 Mylan N.V. Product and Services
2.7.5 Mylan N.V. Adalimumab Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Adalimumab Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Adalimumab Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Adalimumab Manufacturer Market Share in 2019
3.3.2 Top 6 Adalimumab Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Adalimumab Sales, Revenue and Market Share by Regions
4.1.1 Global Adalimumab Sales and Market Share by Regions (2015-2020)
4.1.2 Global Adalimumab Revenue and Market Share by Regions (2015-2020)
4.2 North America Adalimumab Sales and Growth Rate (2015-2020)
4.3 Europe Adalimumab Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Adalimumab Sales and Growth Rate (2015-2020)
4.5 South America Adalimumab Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Adalimumab Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Adalimumab Sales, Revenue and Market Share by Country
5.1.1 North America Adalimumab Sales and Market Share by Country (2015-2020)
5.1.2 North America Adalimumab Revenue and Market Share by Country (2015-2020)
5.2 United States Adalimumab Sales and Growth Rate (2015-2020)
5.3 Canada Adalimumab Sales and Growth Rate (2015-2020)
5.4 Mexico Adalimumab Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Adalimumab Sales, Revenue and Market Share by Country
6.1.1 Europe Adalimumab Sales and Market Share by Country (2015-2020)
6.1.2 Europe Adalimumab Revenue and Market Share by Country (2015-2020)
6.2 Germany Adalimumab Sales and Growth Rate (2015-2020)
6.3 UK Adalimumab Sales and Growth Rate (2015-2020)
6.4 France Adalimumab Sales and Growth Rate (2015-2020)
6.5 Russia Adalimumab Sales and Growth Rate (2015-2020)
6.6 Italy Adalimumab Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Adalimumab Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Adalimumab Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Adalimumab Revenue and Market Share by Regions (2015-2020)
7.2 China Adalimumab Sales and Growth Rate (2015-2020)
7.3 Japan Adalimumab Sales and Growth Rate (2015-2020)
7.4 Korea Adalimumab Sales and Growth Rate (2015-2020)
7.5 India Adalimumab Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Adalimumab Sales and Growth Rate (2015-2020)
7.7 Australia Adalimumab Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Adalimumab Sales, Revenue and Market Share by Country
8.1.1 South America Adalimumab Sales and Market Share by Country (2015-2020)
8.1.2 South America Adalimumab Revenue and Market Share by Country (2015-2020)
8.2 Brazil Adalimumab Sales and Growth Rate (2015-2020)
8.3 Argentina Adalimumab Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Adalimumab Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Adalimumab Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Adalimumab Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Adalimumab Sales and Growth Rate (2015-2020)
9.3 Turkey Adalimumab Sales and Growth Rate (2015-2020)
9.4 Egypt Adalimumab Sales and Growth Rate (2015-2020)
9.5 South Africa Adalimumab Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Adalimumab Sales and Market Share by Type (2015-2020)
10.2 Global Adalimumab Revenue and Market Share by Type (2015-2020)
10.3 Global Adalimumab Price by Type (2015-2020)
11 Global Adalimumab Market Segment by Application
11.1 Global Adalimumab Sales Market Share by Application (2015-2020)
11.2 Global Adalimumab Revenue Market Share by Application (2015-2020)
11.3 Global Adalimumab Price by Application (2015-2020)
12 Market Forecast
12.1 Global Adalimumab Sales, Revenue and Growth Rate (2021-2025)
12.2 Adalimumab Market Forecast by Regions (2021-2025)
12.2.1 North America Adalimumab Market Forecast (2021-2025)
12.2.2 Europe Adalimumab Market Forecast (2021-2025)
12.2.3 Asia-Pacific Adalimumab Market Forecast (2021-2025)
12.2.4 South America Adalimumab Market Forecast (2021-2025)
12.2.5 Middle East & Africa Adalimumab Market Forecast (2021-2025)
12.3 Adalimumab Market Forecast by Type (2021-2025)
12.3.1 Global Adalimumab Sales Forecast by Type (2021-2025)
12.3.2 Global Adalimumab Market Share Forecast by Type (2021-2025)
12.4 Adalimumab Market Forecast by Application (2021-2025)
12.4.1 Global Adalimumab Sales Forecast by Application (2021-2025)
12.4.2 Global Adalimumab Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

Related Categories
Pharmaceuticals
Related Reports
Global Tigecycline Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Tigecycline Market gives an estimation of the development of the market based on historical studies and also provides forecasts  read more..


Global Risperidone Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

The Global Risperidone Market Report is equipped with market data from 2015 to 2025. The report gives a market overview covering key drivers and risks  read more..


Global Caffeine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Caffeine Market gives an estimation of the development of the market based on historical studies and also provides forecasts on  read more..


Global Rabies Vaccine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Rabies Vaccine Market gives an estimation of the development of the market based on historical studies and also provides  read more..


Global Radiopharmaceuticals Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Radiopharmaceuticals Market gives an estimation of the development of the market based on historical studies and also provides  read more..


Global Neurorehabilitation System Market Research Report

The report on the Global Neurorehabilitation System Market gives an estimation of the development of the market based on historical studies and also  read more..


Global Molecular Biology Kits And Reagents Market Research Report

The report on the Global Molecular Biology Kits And Reagents Market gives an estimation of the development of the market based on historical studies and  read more..


Global High Acuity Care Information Systems Market Research Report

The report on the Global High Acuity Care Information Systems Market gives an estimation of the development of the market based on historical studies and  read more..


Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.   A number of factors such as increasing bone related  read more..


Global Skin Cancer Diagnostics Market Research Report

The report on the Global Skin Cancer Diagnostics Market gives an estimation of the development of the market based on historical studies and also  read more..